Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Food on PK of SYR-322 and Metformin FDC in Healthy Japanese Men
NCT02276274Phase 3Completed
- Sponsor
- Takeda
- Start
- Jun 2014
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of alogliptin, liquid metformin (Aspargo Labs) in type 2 diabetes mellitus (T2DM), sponsored by Takeda. Started Jun 2014; status: completed.
02
Drugs
alogliptinliquid metformin (Aspargo Labs)
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02276274.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02276274.